Skip to main content

Table 2 Clinicopathological parameters of the 136 primary melanomas with known sentinel lymph node status

From: H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade

  

H3K27me3 +

H3K27me3−

p value

 

n (%)

n (%)

n (%)

 

Number

136

42 (30,9)

94 (69,1)

 

Age (years): median (range)

59 (20-87)

62 ( 22-84)

58 (20-87)

 

Gender

 Female

60 (44.1)

20 (33.3)

40 (66.7)

p = .583

 Male

76 (55.9)

23 (30.3)

53 (69.7)

 

Thickness: median

 < 1.0 mm

24 (17.6)

5 (20.8)

19 (79.2)

 

 1.01–2.0 mm

61 (44.9)

14 (23.0)

47 (77.0)

p = .033*

 2.01–4.0 mm

32 (23.5)

16 (50.0)

16 (50.0)

 

 > 4 mm

19 (14.0)

7 (36.8)

12 (63.2)

 

Histologic subtype

 Superficial spreading

66 (48.5)

21 (31.8)

45 (68.2)

 

 Nodular

53 (39.0)

17 (32.1)

36 (67.9)

p = .730

 Lentigious malignant

2 (1.5)

0 (0)

2 (100)

 

 Acral melanoma

13 (9.6)

4 (30.8)

9 (69.2)

 

 Other

2 (1.5)

0 (0)

2 (100)

 

Ulceration

 Positive

56 (41.2)

20 (35.7)

36 (64.3)

p = .308

 Negative

80 (58.8)

22 (27.5)

58 (72.5)

 

Sentinel lymph node status

 Positive

32 (23.5)

15 (46.9)

17 (53.1)

p = .025*

 Negative

104 (76.5)

27 (26.0)

77 (74.0)

 

Pigment

 Positive

80 (58.8)

29 (36.2)

51 (63.8)

p = .105

 Negative

56 (41.2)

13 (23.2)

43 (76.8)

 

Tumor-infiltrating lymphocytes

 Absent

58 (42.6)

17 (29.3)

41 (70.7)

p = .872

 Non-brisk

18 (13.2)

5 (27.8)

13 (72.2)

 

 Brisk

60 (44.1)

20 (33.3)

40 (66.7)

 
  1. Samples were analyzed for patient’s age, gender, tumor thickness, histologic subtype, presence of ulceration, sentinel lymph node status, and pigmentation. Tumor-infiltrating lymphocytes were assessed using the scoring system by Clark. Significance was determined by Χ2 test for categorical data (*p < 0.05)